bisoprolol has been researched along with Injury, Myocardial Reperfusion in 2 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Liu, J | 2 |
| Xie, L | 1 |
| Cai, X | 1 |
| Ma, X | 1 |
| Gong, J | 2 |
| Zhang, C | 1 |
| He, S | 1 |
| Li, Y | 1 |
| Li, F | 1 |
| Liu, Z | 1 |
2 other studies available for bisoprolol and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Bisoprolol, a β
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Bisoprolol; Cardiotonic Agents; Disease Models, Ani | 2020 |
Bisoprolol protects myocardium cells against ischemia/reperfusion injury by attenuating unfolded protein response in rats.
Topics: Animals; Bisoprolol; Cardiotonic Agents; Cell Line; Male; Muscle Proteins; Myocardial Reperfusion In | 2017 |